Cargando…
Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review
Sarcopenia refers to the loss of muscle strength and mass in older individuals and is a major determinant of fall risk and impaired ability to perform activities of daily living, often leading to disability, loss of independence, and death. Owing to its impact on morbidity, mortality, and healthcare...
Autores principales: | Jang, Jung Yoon, Kim, Donghwan, Kim, Nam Deuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295434/ https://www.ncbi.nlm.nih.gov/pubmed/37371730 http://dx.doi.org/10.3390/biomedicines11061635 |
Ejemplares similares
-
Pharmacological Interventions for Treatment of Sarcopenia: Current Status of Drug Development for Sarcopenia
por: Kwak, Ju Yeon, et al.
Publicado: (2019) -
Recent Developments in Combination Chemotherapy for Colorectal and Breast Cancers with Topoisomerase Inhibitors
por: Jang, Jung Yoon, et al.
Publicado: (2023) -
Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review
por: Jang, Jung Yoon, et al.
Publicado: (2022) -
Sarcopenia in cirrhosis: from pathogenesis to interventions
por: Ebadi, Maryam, et al.
Publicado: (2019) -
Mechanism of Bile Acid-Induced Programmed Cell Death and Drug Discovery against Cancer: A Review
por: Jang, Jung Yoon, et al.
Publicado: (2022)